D. E. Shaw & Co., Inc. - MARAVAI LIFESCIENCES HLDGS I ownership

MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 210 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q4 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of MARAVAI LIFESCIENCES HLDGS I
ValueSharesWeighting
Q3 2023$7,692,530
+8.9%
769,253
+35.4%
0.01%
+14.3%
Q2 2023$7,063,745
-56.2%
568,282
-50.6%
0.01%
-58.8%
Q1 2023$16,116,306
-21.7%
1,150,343
-20.0%
0.02%
-26.1%
Q4 2022$20,587,854
-1.4%
1,438,704
+76.0%
0.02%
-8.0%
Q3 2022$20,872,000
+50.9%
817,544
+67.9%
0.02%
+56.2%
Q2 2022$13,835,000
+3.1%
486,976
+28.0%
0.02%
+23.1%
Q1 2022$13,416,000
-15.7%
380,381
+0.1%
0.01%0.0%
Q4 2021$15,920,000
-49.7%
379,950
-41.1%
0.01%
-55.2%
Q3 2021$31,647,000
+125.5%
644,802
+91.7%
0.03%
+141.7%
Q2 2021$14,037,000336,3810.01%
Other shareholders
MARAVAI LIFESCIENCES HLDGS I shareholders Q4 2022
NameSharesValueWeighting ↓
GTCR LLC 21,681,033$1,064,105,00026.99%
Ghisallo Capital Management LLC 1,250,000$61,350,0002.33%
Beck Bode, LLC 160,064$7,856,0002.19%
Select Equity Group, L.P. 12,122,011$594,948,300,0002.00%
Pinz Capital Management, LP 83,603$4,103,0001.86%
Monashee Investment Management LLC 185,000$9,080,0001.68%
Ownership Capital B.V. 2,717,559$133,378,0001.51%
Eversept Partners, LP 327,810$16,088,9151.12%
Parkman Healthcare Partners LLC 90,000$4,417,0001.12%
Connacht Asset Management LP 28,569$1,402,0000.91%
View complete list of MARAVAI LIFESCIENCES HLDGS I shareholders